FDA inspection
AbbVie Inc.: FDA inspection ending Feb 16, 2018
FDA inspection 1045001 · No Action Indicated (NAI) · Wyandotte, MI
Key facts
| Inspection ID | 1045001 |
|---|---|
| Firm | AbbVie Inc. |
| FEI number | 3010166391 |
| Address | Lt4 Plant, 1609 Biddle Ave Bldg 63 |
| City | Wyandotte |
| State | MI |
| ZIP | 48192 |
| Country | United States |
| Fiscal year | 2018 |
| Inspection end date | Feb 16, 2018 |
| Classification | No Action Indicated (NAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data